Growth failure and bone lesions due to desferrioxamine in thalassaemic patients

J Pediatr Endocrinol Metab. 1998:11 Suppl 3:957-60.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Blood Transfusion
  • Bone Diseases / chemically induced*
  • Chelating Agents / adverse effects*
  • Child
  • Deferoxamine / adverse effects*
  • Female
  • Growth Disorders / chemically induced*
  • Humans
  • Male
  • beta-Thalassemia / therapy*

Substances

  • Chelating Agents
  • Deferoxamine